Stocks / NASDAQ / Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals Inc.

Our Opinion

Progenics Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing some of their medical products and clinical research.

Supporting Evidence:

The company stated in the following document that they conduct pre-clinical trials of their drugs on animals.

“Importantly, researchers also found that when recombinant soluble PSMA (rsPSMA) was used as a cancer vaccine in an animal model, dimer but not monomer efficiently elicited antibodies that recognized PSMA-expressing tumor cells.” Read the full document

Company Description

Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipelines are therapeutic agents, imaging agents for prostate cancer, and imaging analysis tools.
[Source: MarketWatch]

Company Website: